Hugh McCaughan

Search results

• 2024

  pyRBDome: a comprehensive computational platform for enhancing RNA-binding proteome data

  Chu, L.-C., Christopoulou, N., McCaughan, H., Winterbourne, S., Cazzola, D., Wang, S., Litvin, U., Brunon, S., Harker, P. J., McNae, I. & Granneman, S., Oct 2024, In: Life Science Alliance. 7, 10, 22 p., e202402787.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Proteome 100%
  • RNA Binding 100%
  • RNA 40%
  • Binding Site 40%
  • Amino Acids 20%
• 2023

  Advantages and limitations of UV cross‐linking analysis of protein–RNA interactomes in microbes

  Esteban‐serna, S., Mccaughan, H. & Granneman, S., 19 Oct 2023, In: Molecular Microbiology. 120, 4, p. 477-489 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Cross Linking 100%
  • Protein RNA Binding 100%
  • Microorganism 100%
  • Lifespan 25%
  • Population Research 25%

• The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment

  Purshouse, K., Thomson, J. P., Vallet, M., Alexander, L., Bonisteel, I., Brennan, M., Cameron, D. A., Figueroa, J. D., Furrie, E., Haig, P., Heck, M., Mccaughan, H., Mitchell, P., Mcvicars, H., Primrose, L., Silva, I., Templeton, K., Wilson, N. & Hall, P. S., 31 Jan 2023, In: The Oncologist.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • COVID-19 100%
  • Prevalence 100%
  • Immune Response 100%
  • Tumor Immunity 100%
  • Severe Acute Respiratory Syndrome Coronavirus 2 100%
• 2021

  Infected deep vein thrombophlebitis in people who inject drugs: missed opportunities and potential for alternative antimicrobial approaches.

  McCaughan, H., Russell, C. D. & O'Shea, D., 2 Nov 2021, In: Infection.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Antiinfective Agent 100%
  • Thrombophlebitis 100%
  • Pathogen 40%
  • Pulmonary Embolism 40%
  • Diseases 40%

• Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

  Oxford COVID Vaccine Trial Group, Voysey, M., Costa Clemens, S. A., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., Bibi, S., Briner, C., Cicconi, P., Clutterbuck, E. A., Collins, A. M., Cutland, C. L., Darton, T. C., Dheda, K. & Dold, C. & 61 others, Duncan, C. J. A., Emary, K. R. W., Ewer, K. J., Flaxman, A., Fairlie, L., Faust, S. N., Feng, S., Ferreira, D. M., Finn, A., Galiza, E., Goodman, A. L., Green, C. M., Green, C. A., Greenland, M., Hill, C., Hill, H. C., Hirsch, I., Izu, A., Jenkin, D., Joe, C. C. D., Kerridge, S., Koen, A., Kwatra, G., Lazarus, R., Libri, V., Lillie, P. J., Marchevsky, N. G., Marshall, R. P., Mendes, A. V. A., Milan, E. P., Minassian, A. M., McGregor, A., Mujadidi, Y. F., Nana, A., Padayachee, S. D., Phillips, D. J., Pittella, A., Plested, E., Pollock, K. M., Ramasamy, M. N., Ritchie, A. J., Robinson, H., Schwarzbold, A. V., Smith, A., Song, R., Snape, M. D., Sprinz, E., Sutherland, R. K., Thomson, E. C., Török, M. E., Toshner, M., Turner, D. P. J., Vekemans, J., Villafana, T. L., White, T., Williams, C. J., Douglas, A. D., Hill, A. V. S., Lambe, T., Gilbert, S. C. & Pollard, A. J., 6 Mar 2021, In: The Lancet. 397, 10277, p. 881-891 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • COVID-19 100%
  • Single Drug Dose 100%
  • Pooled Analysis 100%
  • Nucleic Acid Amplification 100%
  • Booster Dose 100%

• Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

  Oxford COVID Vaccine Trial Group, Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., Bibi, S., Briner, C., Cicconi, P., Collins, A. M., Colin-Jones, R., Cutland, C. L., Darton, T. C., Dheda, K. & Duncan, C. J. A. & 63 others, Emary, K. R. W., Ewer, K. J., Fairlie, L., Faust, S. N., Feng, S., Ferreira, D. M., Finn, A., Goodman, A. L., Green, C. M., Green, C. A., Heath, P. T., Hill, C., Hill, H., Hirsch, I., Hodgson, S. H. C., Izu, A., Jackson, S., Jenkin, D., Joe, C. C. D., Kerridge, S., Koen, A., Kwatra, G., Lazarus, R., Lawrie, A. M., Lelliott, A., Libri, V., Lillie, P. J., Mallory, R., Mendes, A. V. A., Milan, E. P., Minassian, A. M., McGregor, A., Morrison, H., Mujadidi, Y. F., Nana, A., O'Reilly, P. J., Padayachee, S. D., Pittella, A., Plested, E., Pollock, K. M., Ramasamy, M. N., Rhead, S., Schwarzbold, A. V., Singh, N., Smith, A., Song, R., Snape, M. D., Sprinz, E., Sutherland, R. K., Tarrant, R., Thomson, E. C., Török, M. E., Toshner, M., Turner, D. P. J., Vekemans, J., Villafana, T. L., Watson, M. E. E., Williams, C. J., Douglas, A. D., Hill, A. V. S., Lambe, T., Gilbert, S. C. & Pollard, A. J., 9 Jan 2021, In: The Lancet. 397, 10269, p. 99-111 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Randomized Controlled Trial 100%
  • COVID-19 100%
  • Interim Analysis 100%
  • Severe Acute Respiratory Syndrome Coronavirus 2 100%
  • SARS Coronavirus 100%